Patent ID: 11939300
Assignee: IMMUNOMOLECULAR THERAPEUTICS, INC.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 14:
15. The method of claim 14, wherein the HLA-DQ2 is selected from the group consisting of: DQ2.5cis (DQA1*05:01-DQB1*02:01), DQ2.5trans (DQA1*05:05-DQB1*03:01/DQA1*02:01-DQB1*02:02), DQ2.2 (DQA1*02:01-DQB1*02:02), and DQ2.3 (DQA1*03:01-DQB1*02:01).